Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics

[1]  He Fei,et al.  High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma , 2022, BioMed research international.

[2]  Shu Yang,et al.  MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma , 2022, Frontiers in Oncology.

[3]  Zhixiong Liu,et al.  Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment , 2022, CNS neuroscience & therapeutics.

[4]  Feng Xu,et al.  DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity , 2022, Oncogene.

[5]  Xiaosong Hu,et al.  ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells. , 2022, Biochemical and biophysical research communications.

[6]  Hongjin Shao,et al.  E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis , 2021, Digestive and Liver Disease.

[7]  Xueran Chen,et al.  Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation , 2021, Oncogenesis.

[8]  M. Eskandani,et al.  Recent advances in γH2AX biomarker-based genotoxicity assays: A marker of DNA damage and repair. , 2021, DNA repair.

[9]  Pei-Li Yao,et al.  Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma , 2021, Oncology reports.

[10]  X. Cai,et al.  E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3 , 2021, Journal of Cancer.

[11]  Yang Jiang,et al.  MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors , 2021, Oncogene.

[12]  H. Cui,et al.  Competing Endogenous RNA Networks in Glioma , 2021, Frontiers in Genetics.

[13]  Jun Li,et al.  Knockdown of MCM8 functions as a strategy to inhibit the development and progression of osteosarcoma through regulating CTGF , 2021, Cell Death & Disease.

[14]  Chaojie Wang,et al.  Long noncoding RNA SNHG9 facilitates growth of glioma stem‐like cells via miR‐326/SOX9 axis , 2021, The journal of gene medicine.

[15]  José A. Guerrero-Martínez,et al.  TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains , 2020, Nature Communications.

[16]  C. P. K. Patro,et al.  A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes , 2020, Human mutation.

[17]  Jiumao Lin,et al.  Identification of mini‐chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancer , 2020, Journal of cellular and molecular medicine.

[18]  H. Saya,et al.  Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma , 2020, Scientific Reports.

[19]  C. Kramm,et al.  Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells , 2020, Cell Death & Disease.

[20]  N. Curtin,et al.  DNA damage checkpoint kinases in cancer , 2020, Expert Reviews in Molecular Medicine.

[21]  H. Cui,et al.  NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR , 2020, Signal Transduction and Targeted Therapy.

[22]  J. Lukas,et al.  Physiological Tolerance to ssDNA Enables Strand Uncoupling during DNA Replication. , 2020, Cell reports.

[23]  Yan Du,et al.  E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2 , 2020, Journal of cellular and molecular medicine.

[24]  Huirong Shi,et al.  ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer , 2020, Therapeutic advances in medical oncology.

[25]  Y. Drew,et al.  Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations? , 2019, Pharmacology & therapeutics.

[26]  J. Komorowski,et al.  Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas , 2019, Nature Communications.

[27]  Monica Stanciu,et al.  Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma , 2019, Nature Communications.

[28]  A. Dubrovska,et al.  Cancer Stem Cells and Radioresistance: DNA Repair and Beyond , 2019, Cancers.

[29]  Atique U. Ahmed,et al.  Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma , 2018, Cell Death and Disease.

[30]  A. LeBeau,et al.  The role of CD133 in cancer: a concise review , 2018, Clinical and Translational Medicine.

[31]  J. Sarkaria,et al.  H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers , 2018, eLife.

[32]  E. Lecona,et al.  Targeting ATR in cancer , 2018, Nature Reviews Cancer.

[33]  J. Sarkaria,et al.  Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues , 2018, Genome Biology.

[34]  T. Ochiya,et al.  Drug Resistance Driven by Cancer Stem Cells and Their Niche , 2017, International journal of molecular sciences.

[35]  N. Oleinick,et al.  ATR/CHK1 inhibitors and cancer therapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  H. Clevers,et al.  Cancer stem cells revisited , 2017, Nature Medicine.

[37]  R. Benhida,et al.  ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells. , 2017, MedChemComm.

[38]  J. Wysocka,et al.  Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution , 2016, Cell.

[39]  J. Parker,et al.  ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation , 2016, Development.

[40]  L. J. Lee,et al.  Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. , 2016, Cancer cell.

[41]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[42]  F. Gage,et al.  Enhancer Divergence and cis-Regulatory Evolution in the Human and Chimp Neural Crest , 2015, Cell.

[43]  A. Ryan,et al.  ATM and ATR as therapeutic targets in cancer. , 2015, Pharmacology & therapeutics.

[44]  C. Glass,et al.  The selection and function of cell type-specific enhancers , 2015, Nature Reviews Molecular Cell Biology.

[45]  Yuanyi Feng,et al.  The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation , 2014, eLife.

[46]  R. Muschel,et al.  Targeting ATR in DNA damage response and cancer therapeutics. , 2014, Cancer treatment reviews.

[47]  J. Wysocka,et al.  Modification of enhancer chromatin: what, how, and why? , 2013, Molecular cell.

[48]  Y. Mao,et al.  B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium , 2013, Chinese journal of cancer.

[49]  E. Furlong,et al.  Transcription factors: from enhancer binding to developmental control , 2012, Nature Reviews Genetics.

[50]  L. Truong,et al.  Dbf4 Is Direct Downstream Target of Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) Protein to Regulate Intra-S-phase Checkpoint* , 2011, The Journal of Biological Chemistry.

[51]  M. Hidalgo,et al.  Inhibition of Ataxia Telangiectasia‐ and Rad3 ‐Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor‐Initiating Cell Fraction , 2011, Stem cells.

[52]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[53]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[54]  O. Cuvier,et al.  MCM8 Is an MCM2-7-Related Protein that Functions as a DNA Helicase during Replication Elongation and Not Initiation , 2005, Cell.

[55]  Kai Rothkamm,et al.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Shota Katayama,et al.  Isolation and characterization of cancer stem cells derived from human glioblastoma. , 2021, American journal of cancer research.

[57]  P. Godoy,et al.  E2F transcription factors associated with up-regulated genes in glioblastoma. , 2017, Cancer biomarkers : section A of Disease markers.

[58]  R. Schneider,et al.  Lateral Thinking: How Histone Modifications Regulate Gene Expression. , 2016, Trends in genetics : TIG.

[59]  W. Weiss,et al.  Glial progenitors as targets for transformation in glioma. , 2014, Advances in cancer research.

[60]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..